Abdominal Neoplasms  >>  iniparib (BSI 201)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iniparib (BSI 201) / Sanofi
NCT00677079: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Completed
2
12
US
Iniparib, BSI-201, SAR240550
Sanofi
Primary Peritoneal Cancer, Advanced Epithelial Ovarian Cancer
12/08
12/08

Download Options